Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081

Journal of Immunology

Volumn 156, Issue 6, 1996, Pages 2221-2230

  Van Zee, Kimberly J ^a   Moldawer, Lyle L ^a,e   Oldenburg, Hester S A ^a   Thompson, William A ^a   Stackpole, Sarah A ^a   Montegut, Walton J ^a   Rogy, Michael A ^a   Meschter, Carol ^b,f   Gallati, Harald ^c   Schiller, Claus Dieter ^c   Richter, Wolfgang F ^c   Loetscher, Hansruedi ^c   Ashkenazi, Avi ^d   Chamow, Steven M ^d   Wurm, Florian ^d,g   Calvano, Steve E ^a   Lowry, Stephen F ^a   Lesslauer, Werner ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d GENENTECH INC   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f Veterinary Pathology Consultants   (United States)

^g EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; HYBRID PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LENERCEPT; PROTHROMBIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; BACTEREMIA; CONTROLLED STUDY; DOSE RESPONSE; ENTEROBACTER INFECTION; FEMALE; FIBRINOGEN BLOOD LEVEL; GRANULOCYTOPENIA; HEMODYNAMICS; LACTATE BLOOD LEVEL; MALE; MORTALITY; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SEPSIS; TISSUE INJURY;

ANIMALS; ANTIGENS, CD; BACTEREMIA; BLOOD COAGULATION; BLOOD GAS ANALYSIS; ESCHERICHIA COLI INFECTIONS; FEMALE; HEMODYNAMIC PROCESSES; IMMUNOGLOBULIN G; LEUKOPENIA; MALE; MOLECULAR WEIGHT; PAPIO; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT FUSION PROTEINS; THROMBOCYTOPENIA;

EID: 13344270905     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF: a primary mediator of the host response. Annu Rev Immunol. 7:625.
2. Beutler, B. 1992. Tumor Necrosis Factors: The Molecules and Their Emerging Rote in Medicine. Raven Press, New York.
3. Vassalh, P. 1992. The pathophysiology of tumor necrosis factors Annu. Rev. Immunol. 10:411.
4. Hesse, D. G., K. J. Tracey, Y Fong, K. R. Manogue, M. A. Palladino, A. Cerami, G. T. Shires, and S. F. Lowry. 1988. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol. Obstet. 166:147.
5. Michie, H R., K. R. Manogue, D. R Spriggs, A. Revhaug, S. O'Dwyer, C. A. Dinarello, A Cerami, S. M. Wolff, and D. W. Willmore. 1988 Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318.1481.
6. Fong, Y., M. A. Marano, L. L. Moldawer, H. Wei, S E. Calvano, J S. Kenney, A. C. Allison, A Cerami, G T. Shires, and S F. Lowry. 1990. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J. Clin. Invest. 85.1896.
7. van Deventer, S. J. H., H. R. Buller, J W. ten Cate, L A. Aarden, C. E. Hack, and A. Sturk. 1990. Experimental endotoxemia in humans, analysis of cytokine release and coagulation, fibrinolytic and complement pathways Blood 76.2520.
8. van Zee, K., L. deForge, E. Fischer, M A Marano, J. S. Kenney, D G. Remick, S. F. Lowry, and L L Moldawer. 1991. IL-8 in septic shock, endotoxemia and following IL-1 administration J. Immunol 146 3478.
9. Tracey, K., B. R. Beutler, S. F. Lowry, J Merryweather, S. Wolpe, I. W. Milsark, R J Hanri, T. J Fahey, A. Zentella, J. D Albert, G. T Shires, and A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470
10. Tracey, K , S. F. Lowry, T. J. Fahey, J. D Albert, Y Fong, D. Hesse, B R Beutler, K. R. Manogue, S Calvano, H. Wei, A Cerami, and G. T. Shires 1987. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog Surg Gynecol. Obstet 164 415.
11. Redl, H., G. Schlag, M. Ceska, J. Davies, and W. A. Buurman. 1993. Interleukin-8 release in baboon septicemia is partially dependent on tumor necrosis factor. J. Infect Dis. 167:1464
12. Redl, H , G. Schlag, S. Bahrami, R. Kargl, W. Hartter, W. Woloszczuk, and J Davies. 1994 Big-endothelin release in baboon bacteremia is partially TNF dependent. J. Lab. Clin. Med. 124.796
13. Redl, H , G. Schlag, A. Schiesser, and J. Davies 1995. Thrombomodulin release in baboon sepsis: its dependence on the dose of Escherichia coli and the presence of tumor necrosis factor. J. Infect. Dis. 171 1522
14. Tracey, K., Y Fong, D G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia Nature 330.662.
15. Hinshaw, I. B., P. Tekamp-Olsen, A. C. Ghana, P A. Lee, F. B. Taylor, C. K Murray, G T. Peer, T E Emerson, R B. Passey, and G. C. Kuo. 1990. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor Circ Shock 30:279
16. Lesslauer, W., H. Tabuchi, R Gentz, M Brockhaus, E. J. Schlaeger, G Grau, P F. Piguet, P. Pointaire, P Vassalli, and H R Loetscher. 1991. Recombinant soluble TNF receptor proteins protect mice from LPS-induced lethality Eur J. Immunol 21.2883.
17. Ashkenazi, A., S. A. Marsters, D. J. Capon, S. M. Chamow, I. S. Figari, P Pennica, D. V. Goeddel, M. A. Palladino, and D. H. Smith 1991. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci. USA 88:10535.
18. Peppel, K , D. Crawford, and B. Beutler. 1991. A tumor necrosis factor receptor IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J. Exp. Med. 174:1483
19. van Zee, K. J., T. Kohno, E Fischer, C S. Rock, L L. Moldawer, and S F. Lowry. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor a in vitro and in vivo. Proc. Natl. Acad. Sci USA 89:4845
20. Mohler, K. M., D S. Torrance, C. A. Smith, R E. Goodwin, K. E. Stremler, V. P. Fung, H. Madani, and M B. Widmer. 1993 Soluble tumor necrosis factor receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF earners and TNF antagonists. J Immunol 151:1548.
21. Evans, T. J , D Moyes, A. Carpenter, R. Martin, H. Loetscher, W. Lesslauer, and J. Cohen. 1994. Protective effect of 55 kD but not 75 kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of Gramnegative sepsis. J. Exp. Med. 180:2173.
22. Seckinger, P., S Isaaz, and J. M. Dayer. 1988 A human inhibitor of tumor necrosis factor. J. Exp. Med. 167:1511.
23. Engelmann, H., D. Aderka, M. Rubinstein, D Rotman, and D Wallach. 1989. A tumor necrosis factor binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J. Biol. Chem 264:21974.
24. Lantz, M., U Gullberg, E. Nillson, and I Olsson 1990. Characterization in vitro of a human tumor necrosis factor binding protein: a soluble form of the tumor necrosis factor receptor. J. Clin. Invest 86:1396.
25. Girardin, E., P. Roux-Lombard, and G. E. Grau. 1992. Imbalance between tumor necrosis factor and soluble TNF receptor concentrations in severe meningococcemia. Immunol. 76:20.
26. Digel, W., F Porzsolt, M Schmid, F. Hermann, W. Lesslauer, and M Brockhaus. 1992 High levels of circulating soluble receptors for tumor necrosis factor in chronic B-lymphocytic leucemia and hairy cell leucemia. J. Clin. Invest. 89:1690.
27. Aderka, D., H Engelmann, Y Maor, C. Brakebusch, and D. Wallach 1992. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175:323.
28. Banner, D., A D'Arcy, W. Janes, R. Gentz, H. J. Schoenfeld, C. Broger, H. Loetscher, and W. Lesslauer. 1993 Crystal structure of the soluble human 55-kd TNF receptor-human TNF-β complex: implications for TNF receptor activation. Cell 73:431
29. Loetscher, H R , P Angehrn, E. J. Schlaeger, R. Gentz, and W. Lesslauer. 1993. Efficacy of a chimeric TNFR-IgG fusion protein to inhibit TNF activity in animal models of septic shock. In Bacterial Endotoxin: Recognition and Effector Mechanisms, Endotoxin Research Series, Vol. 2. J. Levin. C. R Alving, R. S. Munford, and P. L. Stutz, eds. Excerpta Medica, Amsterdam, pp. 455-462.
30. Abraham, E , R Wunderitik, H Silverman, T. M. Perl, S. Nasraway, H. Levy, R. Bone, R P Wenzel, R. Balk, R Allred, J. E. Pennington, J C Wherry, and T.-A. S. S. Group. 1995 Efficacy and safety of monoclonal antibody to human tumor necrosis factor a in patients with sepsis syndrome. JAMA 273:934.
31. Exley, A R., J Cohen, W. Buurman, R. Owen, J. Lumley, M. Bodmer, S. Stephens, G. Hanson, J. M. Aulakh, A. Riddell, and M. Perry 1990. Monoclonal antibody to TNF in severe septic shock. Lancet 335-1275.
32. Fisher, C. J., Jr., S M Opal, J F. Dhainaut, S Stephens, J. L. Zimmerman, P. Nightingale, S. J. Harris, R M. H. Schein, E. A Panacek, J. L. Vincent, G E. Fouike, E L Warren, C. Garrard, G Park, M. W Bodmer, J Cohen, C. van der Linden, A. S. Cross, J. C. Sadoff, and T. C. S. S S. group. 1993. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit. Care Med 21.318.
33. Fisher, C. J., Jr., , J. F. A. Dhainaut, S M. Opal, J. P. Pribble, R. A. Balk, G J Slotman, T. J. Iberti, E. C Rackow, M. J Shapiro, R. L. Greenman, H. D Reines, M P Shelly, B. W. Thompson, J. F. LaBrecque, M. A. Catalane, W. A Knaus, J. C. Sadoff, and P. I. R.-R. S S. S. Group. 1994 Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome JAMA 271-1836
34. Fisher, Jr., C. J., G. J. Slotman, S. M. Opal, J. P Pribble, R. C Bone, G. Emmanuel, D. Ng, D C. Bloedow, and M. A. Catalano. 1994. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open label, placebo-controlled multicenter trial, the IL-1RA sepsis syndrome study group. Crit. Care Med. 22:12
35. Fisher, Jr , C. J., S M. Opal, S. F. Lowry, J. C. Sadoff, J F LaBrecquc, H C. Donovan, J. L. Lookabough, J. Lemke, J. P. Pribble, S C. Stromatt, G P Vigers, D. A. Russell, and R. C. Thompson. 1994. Role of interleukin-1 and the therapeutic potential of interleukin-1 receptor antagonist in sepsis Circ. Shock 44:1.
36. Quezado, Z. M., S. M. Banks, and C. Natanson. 1995. New strategies for combatting sepsis: the magic bullet missed the mark, but the search continues Trends Biotechnol 13.56.
37. Abraham, E., M. Glauser, D. Gelmont, K. Kudsk, D. Lew, J. Carlet, and Leighton. 1995. Ro 45-2081 (TNFR55-IgG1) in the treatment of patients with severe sepsis, and septic shock: preliminary results. In Sec. Intern. Autumnal Them. Meeting on Sepsis Deauville, France
38. Loetscher, H R , R. Gentz, M. Zulauf, A. Lustig, H Tabuchi, E. J. Schlaeger, M. Brockhaus, H. Gallati, M. Manneberg, and W. Lesslauer 1991 Recombinant 55-kDa TNF receptor stoichiornetry of binding to TNF-alpha and TNF-beta and inhibition of TNF activity. J Biol. Chem 266:18324.
39. Fischer, E., M. A. Marano, K. J. van Zee, C. S. Rock, A. S. Hawes, W. A Thompson, L. deForge, J. S. Kenney, D. G Remick, D. C Bloedow, R C. Thompson, S. F. Lowry, and L. L. Moldawer. 1992. Interleukin 1 receptor blockade improves survival and hemodynamic performance in Escherichia call septic shock, but fails to alter host responses to sublethal endotoxemia J. Clin Invest. 89:1551.
40. Fong, Y., K J. Tracey, L. L. Moldawer, D. G Hesse, K R. Manogue, J. Kenney. A. T. Lee, G. C. Kuo, A. Allison, S. F. Lowry, and A. Cerami 1989 Antibody to cachectin/tumor necrosis factor attenuates interleukin-1 beta and interleukin-6 appearance during overwhelming bacteremia J Exp Med. 170:1627
41. Lantz, M., S. Malik, I. Slevin, and I. Olsson. 1990. Infusion of tumor necrosis factor causes an increase in circulating TNF binding proteins in humans Cytokine 2.403.
42. van Zee, K. J , S. A Stackpole, W J. Montegut, M. A Rogy, S. E. Calvano, K. C Hsu. M Chao, C. M. Meschter, H. R. Loetscher, D. Stueber, U Ettlin, B Wipf. W, Lesslauer, S. F Lowry, and L. L. Moldawer. 1994 A human TNF-α mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon J. Exp. Med. 179:1185.
43. van der Poll, T , T. Buller, H. R ten Cate, C. H. Wortel, K. A. Bauer, S J H van Deventer, C. E. Hack, H P Sauerwem, R. D Rosenburg, and J. W ten Cate 1990. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N. Engl. J. Med. 322:1622.
44. Echtenacher, B , W. Falk, D. N. Mannel, and P. H. Krammer 1990 Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145-3762
45. Bagby, G. J., K. J. Plessala, L A. Wilson, J. J Thompson, and S Nelson 1991 Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis J. Infect Dis. 163:83.